MD20050040A - Method of normalizing the functional activity of lymphocytes - Google Patents
Method of normalizing the functional activity of lymphocytesInfo
- Publication number
- MD20050040A MD20050040A MDA20050040A MD20050040A MD20050040A MD 20050040 A MD20050040 A MD 20050040A MD A20050040 A MDA20050040 A MD A20050040A MD 20050040 A MD20050040 A MD 20050040A MD 20050040 A MD20050040 A MD 20050040A
- Authority
- MD
- Moldova
- Prior art keywords
- normalizing
- lymphocytes
- functional activity
- bior
- immunology
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention refers to medicine, namely to immunology.The method of normalizing the functional activity of lymphocytes, according to the invention, includes administration of the BioR preparation in capsules, containing 5,0 mg of active substance, per os, two times a day, during 20 days.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20050040A MD20050040A (en) | 2005-02-09 | 2005-02-09 | Method of normalizing the functional activity of lymphocytes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20050040A MD20050040A (en) | 2005-02-09 | 2005-02-09 | Method of normalizing the functional activity of lymphocytes |
Publications (1)
Publication Number | Publication Date |
---|---|
MD20050040A true MD20050040A (en) | 2006-08-31 |
Family
ID=62142841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20050040A MD20050040A (en) | 2005-02-09 | 2005-02-09 | Method of normalizing the functional activity of lymphocytes |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD20050040A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2162705C2 (en) * | 1999-03-29 | 2001-02-10 | Первушкин Сергей Васильевич | Drug "rastospir" showing hepatoprotective, immunomodulating and antioxidative effects and biologically active addition based on thereof |
UA58838A (en) * | 2002-11-08 | 2003-08-15 | Інститут Фтизіатрії І Пульмонології Ім. Ф.Г. Яновського Академії Медичних Наук України | Method for treating tuberculosis in children |
MD2355G2 (en) * | 2003-08-07 | 2004-07-31 | Валериу РУДИК | Method of preimplanting preparation |
-
2005
- 2005-02-09 MD MDA20050040A patent/MD20050040A/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2162705C2 (en) * | 1999-03-29 | 2001-02-10 | Первушкин Сергей Васильевич | Drug "rastospir" showing hepatoprotective, immunomodulating and antioxidative effects and biologically active addition based on thereof |
UA58838A (en) * | 2002-11-08 | 2003-08-15 | Інститут Фтизіатрії І Пульмонології Ім. Ф.Г. Яновського Академії Медичних Наук України | Method for treating tuberculosis in children |
MD2355G2 (en) * | 2003-08-07 | 2004-07-31 | Валериу РУДИК | Method of preimplanting preparation |
Non-Patent Citations (3)
Title |
---|
<http://www.google.com/search?hl=en&q=%22spirulina+%28arthrospira%29%3A+ an+edible+microorganism.+A+review.%22&btnG=Google+Search> * |
№7-8, 2004 год. ПЕРСПЕКТИВЫ ИСПОЛЬЗОВАНИЯ СПИРУЛИНЫ ДЛЯ СОЗДАНИЯ ЛЕКАРСТВ, < http://rosapteki.ru/arhiv/detail.php?ID= * |
А.В., ПЕРВУШКИН С.В., ШАТАЛАЕВ И.Ф., Самарский государственный медицинский университет. Российские аптеки, * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007143652A3 (en) | Chewable soft gelatin capsules | |
UA96449C2 (en) | Stable laquinimod preparations | |
WO2008070346A3 (en) | Methods for treating pain with reduced nuasea and vomiting | |
WO2009002867A3 (en) | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement | |
TNSN08140A1 (en) | ||
SI1778680T1 (en) | Spirocyclic cyclohexane derivatives | |
TW200600120A (en) | Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance | |
BRPI0513598A (en) | enteric release coated tablet dosage forms | |
MY139086A (en) | Use of debranched starch in extrusion-spheronization pharmaceutical pellets | |
TW200612903A (en) | Use of trisubstituted benzopyranones | |
ECSP066860A (en) | ORAL MATRIX FORMULATIONS THAT INCLUDE LICARBAZEPINA | |
GB2443793B (en) | Product, method of manufacture and use | |
BR0311189A (en) | Flibanserin polymorphic a-containing pharmaceutical compositions | |
NO20064783L (en) | Solution tablets with licarbazepine | |
WO2008128191A3 (en) | Oral cephalotaxine dosage forms | |
TW200503785A (en) | Dosage form containing (S)-pantoprazole as active ingredient | |
TN2010000008A1 (en) | Oral pharmaceutical solutions containing telbivudine | |
MD20050040A (en) | Method of normalizing the functional activity of lymphocytes | |
WO2005056520A8 (en) | Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy | |
MY141008A (en) | Oral formulations of deoxypeganine and their uses | |
AR025392A1 (en) | PHARMACEUTICAL PREPARATION | |
TW200626133A (en) | Oral medication for twice-daily administration | |
NZ596881A (en) | Phentermine liquid dosage form | |
MD20050038A (en) | Process for immunocorrection of organism natural resistance | |
UA11418U (en) | Method for complex therapy of osteoarthrosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC9A | Refusal of application (patent for invention) |